-- 
EU Extends Review of Teva, Cephalon Deal After Remedies

-- B y   P e t e r   C h a p m a n
-- 
2011-09-23T09:00:33Z

-- http://www.bloomberg.com/news/2011-09-23/eu-extends-review-of-teva-cephalon-deal-after-remedies.html
The European Commission extended
its review of  Teva Pharmaceutical Industries Ltd. (TEVA) ’s bid for
 Cephalon Inc. (CEPH)  after it was offered remedies to allay possible
competition concerns over the deal.  The new deadline is Oct. 13, the commission said in a
filing on its website today. It didn’t specify the remedies that
were offered.  To contact the editor responsible for this story:
Peter Chapman at 
 pchapman10@bloomberg.net  